| Paper | Title | Page |
|---|---|---|
| MOP15 | The ISOLPHARM Project for the Production of High Specific Activity Radionuclides for Medical Applications | 91 |
|
||
|
ISOLPHARM is a branch of the INFN-LNL SPES project*, aimed at the production of radioisotopes for medical applications according to the ISOL technique. Such an innovative method will allow to obtain radiopharmaceuticals with very high specific activity. In this context a primary proton beam, extracted from a cyclotron will directly impinge a target, where the produced isotopes are extracted and accelerated, and finally, after mass separation, only the desired nuclei are deposed on a secondary target. This work is focused in the design and study of the aforementioned production targets for a selected set of isotopes, in particular for 64Cu, 89Sr, 90Y, 125I and 131I. 64Cu will be produced impinging Ni targets, otherwise the SPES UCx target is planned to be used. Different target configurations are being studied by means of the Monte Carlo based code FLUKA for the isotope production calculation and the Finite Element Method based software ANSYS ® for the temperature level evaluation. An appropriate secondary target substrate for implanting the produced isotopes is under study alongside with a system for its dissolution and repartition into radiopharmaceutical doses.
* A. Monetti et al., The RIB production target for the SPES project, Eur. Phys. J. A (2015) 51:128 |
||
| Export • | reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml) | |